Testing a Hybrid Fractional Laser for Treating Acne Scars in Adults with Skin of Color

What this Trial Is About

Researchers are studying the effectiveness and tolerability of a hybrid non-ablativeablative laser called the Sciton Halo for treating acne scars, especially in people with darker skin tones Fitzpatrick IV and V. Acne scarring can negatively impact quality of life and mental health, and current treatments have limited evidence for their benefit. This study focuses on improving acne scars with this newer laser technology that combines two wavelengths for targeted skin treatment. Participants receive treatment with the Sciton Halo hybrid fractional laser in two groups based on skin type. Each group will have 23 participants with either Fitzpatrick skin types IV-V or I-III. At the first visit, participants provide consent, receive education on the procedure and sun care, and are given sunscreen. They may be prescribed hydroquinone or retinol to prevent hyperpigmentation, starting treatment after one month if they choose. Treatment involves up to three laser sessions, with the number depending on improvement. Before and after photos are taken at each session, and participants complete quality of life and satisfaction surveys. During the study, participants will be monitored regularly up to nine months. Assessments include changes in acne scar severity, clinician and patient evaluations of improvement, skin texture, pigmentation, and overall satisfaction. Researchers will also track adherence to skin care, sunscreen use, sun avoidance, side effects, and pain. The study aims to measure both clinical outcomes and patient experiences over time to evaluate the lasers impact on acne scars in skin of color.

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color